FDA Offers Advice on When to File and ANDA or 505(b)(2) Application

Drug Industry Daily
A A
The FDA released final guidance for sponsors on whether to submit an ANDA or a 505(b)(2) new drug application.

To View This Article:

Login

Subscribe To Drug Industry Daily